David Ochayon retweeted
Check out our recent discovery that challenges the current paradigm that defective natural killer cell activity contributes to allergic disease development. @ScienceMagazine @DOchayon @LabWaggoner @GKhuranaHershey
science.org/doi/10.1126/scii…
David Ochayon retweeted
IL-6 and IL-27 play both distinct and redundant roles in
regulating CD4 T-cell responses during chronic viral infection @ZunigaLab
frontiersin.org/articles/10.…
2B4 inhibits the apoptosis of natural killer cells through phosphorylated extracellular signal-related kinase/B-cel… pubmed.ncbi.nlm.nih.gov/3751…
2
81
David Ochayon retweeted
Exciting data on the NKp44-HLA-DP interaction in Ulcerative Colitis sciencedirect.com/science/ar…
David Ochayon retweeted
Scientists from @UniOslo @Oslounivsykehus proposed a treatment strategy involving an engineered antibody to block T cells’ recognition of #gluten antigens in order to prevent the development of #celiac disease.
📄: scim.ag/3mN #WeekendReads
David Ochayon retweeted
The Sim lab is now real and we're officially hiring!
I recently got an MRC Fellowship and am now recruiting a Research Assistant and a PostDoc very soon.
RA job is live: shorturl.at/HRSX9
Come to Oxford and do cool science on NK cells and KIR.
Please share!
David Ochayon retweeted
We have a post-doc position available focused on intestinal and cancer immunology. Ideal for PhD students soon to submit, who want to work with some cool in vivo models to better understand immune responses. Position advertised on BSI Jobs Board
immunology.org/careers/bsi-j…
David Ochayon retweeted
Two 2021 studies described T cell drivers of hard-to-treat #allergic diseases—food allergen-triggered eosinophilic #esophagitis and chronic #rhinosinusitis with nasal polyps. #WeekendReads
From @kochinstitute: scim.ag/3hF
From @MTC_KI: scim.ag/3hG
David Ochayon retweeted
Prolonged T cell - DC macro-clustering within lymph node microenvironments initiates Th2 cell differentiation in a site specific manner biorxiv.org/cgi/content/shor… #biorxiv_immuno
David Ochayon retweeted
Tumor cells are infamously skilled masters of immune disguise, but research from @CellReproLab shows that forcing them to present antigens can boost anti-cancer immune activity. @lunduniversity scim.ag/3gN
David Ochayon retweeted
Neuron-dependent tuft cell expansion initiates sinonasal allergic Type 2 inflammation biorxiv.org/cgi/content/shor… #biorxiv_immuno
David Ochayon retweeted
Virtual memory #Tcells—#immune cells that display memory features even without prior pathogen exposure—act as a bridge between innate and adaptive responses at the site of infection, suggested a 2021 @Tsinghua_Uni study in mice.
📄: scim.ag/3cB #WeekendReads
David Ochayon retweeted
IgG sialylation occurs via the FcRn-mediated recycling pathway in endothelial cells biorxiv.org/cgi/content/shor… #biorxiv_immuno
David Ochayon retweeted
Allelic Variation of KIR and HLA Tunes the Cytolytic Payload and Determines Functional Hierarchy of NK Cell Repertoires
doi.org/10.1182/bloodadvance…
@MalmbergLab @PN0rmski
David Ochayon retweeted
Successful placentation in human pregnancy is regulated by reciprocal interactions between maternal uterine NK cells and fetal placental trophoblast
biorxiv.org/content/10.1101/…
Wonderful work from Ashley and her team.
David Ochayon retweeted
Scientists revealed in 2021 that inhalation of the molecule IFNβ switched inflammatory dendritic cells into those that induce tolerance and are anti-inflammatory, helping alleviate #asthma in mice: scim.ag/2X8 @UFMedicine @UFSurgery #WeekendReads
David Ochayon retweeted
Expanded clinical-grade NK cells exhibit stronger effects than primary NK cells against HCMV infection
nature.com/articles/s41423-0…











